News and Announcements

Amy E. Krambeck, MD, discusses the key advantages of holmium laser enucleation of the prostate (HoLEP), highlighting its effectiveness, precision, and benefits for patient recovery.

A team of Northwestern scientists have developed a novel “scaffolding” biomaterial that improves bladder tissue regeneration and overall function better than current techniques.

A new blood test may help reduce unnecessary prostate biopsies and can detect prostate cancer with similar sensitivity to standard screening in patients across racial and ethnic groups, according to a recent study published in the Journal of Clinical Oncology.

As part of the “Voices” series presented by the Diversity, Equity & Inclusion Committee, this episode features an inspiring conversation between Dr. Gjanje Smith-Mathus, a female pelvic medicine and reconstructive surgeon at WakeMed and founder of the Susu Health Foundation, and Dr. Jennifer Miles-Thomas, Vice Chair of Integration and Innovation at the Northwestern Medicine Department of Urology and AUA treasurer-elect. Dr. Miles-Thomas shares her historic journey as the first woman—and woman of color—on the AUA Board of Directors, highlighting the significance of representation and diversity in leadership within the medical field.

In this episode of Better Edge, Hiten D. Patel, MD, explores his groundbreaking research on harnessing artificial intelligence to enhance the accuracy of prostate cancer detection and staging. Dr. Patel shares insights into the transformative potential of AI in revolutionizing diagnostic precision and improving patient outcomes in prostate cancer care.

A new Northwestern Medicine study suggests using an alternative approach to prostate biopsy is as effective at detecting cancer as the current approach, but without the risk of infection or need for prophylactic antibiotics.

Investigators have discovered that aberrant activation of a specific oncoprotein drives key tumor promoting changes in the prostate tissue microenvironment during cancer progression, according to a Northwestern Medicine study published in Nature Communications.

In this Urology Times interview, Catherine S. Nam, MD, a clinical andrology fellow at Northwestern University, discusses the motivation behind and significant findings of her study, “Short-Term Changes in Vasectomy Consults and Procedures Following Dobbs v. Jackson Women’s Health Organization.” Dr. Nam delves into the implications of the landmark decision and its impact on vasectomy trends, offering a unique perspective on the intersection of reproductive healthcare and societal change.

RNA modifications could serve as a therapeutic target for certain types of cancer, according to a new study published in Molecular Cell which sheds new light on the complex process underlying RNA transcription.

Edward M. Schaeffer, MD, PhD, outlines Northwestern Medicine's strategic growth in urology and healthcare administration, highlighting partnerships and expansions over the past decade. Under his leadership since 2015, the department has established a robust team of 18 urologists across 8 sites within an 11-hospital system serving Chicagoland, integrating quality standards, education, and marketing to ensure consistent, high-quality care across geographic regions

Patients with metastatic urothelial cancer and increased expression of the NECTIN4 gene had a dramatically better response to antibody treatment than patients with reduced gene expression, according to recent findings published in the Journal of Clinical Oncology.